• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VMAT2 缺陷型小鼠表现出黑质和非黑质纹状体的病理学改变,以及帕金森病的运动和非运动症状。

VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease.

机构信息

Department of Environmental Health, Rollins School of Public Health, Emory University, 1518 Clifton Road, Atlanta, GA 30322, USA.

出版信息

Parkinsons Dis. 2011 Feb 21;2011:124165. doi: 10.4061/2011/124165.

DOI:10.4061/2011/124165
PMID:21403896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3043293/
Abstract

Dopamine is transported into synaptic vesicles by the vesicular monoamine transporter (VMAT2; SLC18A2). Disruption of dopamine storage has been hypothesized to damage the dopamine neurons that are lost in Parkinson's disease. By disrupting vesicular storage of dopamine and other monoamines, we have created a progressive mouse model of PD that exhibits catecholamine neuron loss in the substantia nigra pars compacta and locus coeruleus and motor and nonmotor symptoms. With a 95% reduction in VMAT2 expression, VMAT2-deficient animals have decreased motor function, progressive deficits in olfactory discrimination, shorter latency to behavioral signs of sleep, delayed gastric emptying, anxiety-like behaviors at younger ages, and a progressive depressive-like phenotype. Pathologically, the VMAT2-deficient mice display progressive neurodegeneration in the substantia nigra (SNpc), locus coeruleus (LC), and dorsal raphe (DR) coupled with α-synuclein accumulation. Taken together, these studies demonstrate that reduced vesicular storage of monoamines and the resulting disruption of the cytosolic environment may play a role in the pathogenesis of parkinsonian symptoms and neurodegeneration. The multisystem nature of the VMAT2-deficient mice may be useful in developing therapeutic strategies that go beyond the dopamine system.

摘要

多巴胺通过囊泡单胺转运体(VMAT2;SLC18A2)被转运到突触小泡中。储存多巴胺的破坏被假设会损害帕金森病中丢失的多巴胺神经元。通过破坏多巴胺和其他单胺类物质的囊泡储存,我们创建了一种进行性的 PD 小鼠模型,该模型在黑质致密部和蓝斑中表现出儿茶酚胺神经元的丧失以及运动和非运动症状。VMAT2 表达减少 95%,VMAT2 缺陷动物的运动功能下降,嗅觉辨别能力逐渐下降,睡眠行为迹象的潜伏期缩短,胃排空延迟,年龄较小的焦虑样行为,以及进行性抑郁样表型。病理性检查显示,VMAT2 缺陷小鼠的黑质(SNpc)、蓝斑(LC)和中缝背核(DR)出现进行性神经退行性变,同时伴有α-突触核蛋白的积累。综上所述,这些研究表明,单胺类物质的囊泡储存减少以及由此导致的细胞溶质环境的破坏可能在帕金森症状和神经退行性变的发病机制中发挥作用。VMAT2 缺陷小鼠的多系统性质可能有助于开发超越多巴胺系统的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ff/3043293/fe48127e7dc1/PD2011-124165.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ff/3043293/adcee1091a65/PD2011-124165.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ff/3043293/fe48127e7dc1/PD2011-124165.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ff/3043293/adcee1091a65/PD2011-124165.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b8ff/3043293/fe48127e7dc1/PD2011-124165.002.jpg

相似文献

1
VMAT2-Deficient Mice Display Nigral and Extranigral Pathology and Motor and Nonmotor Symptoms of Parkinson's Disease.VMAT2 缺陷型小鼠表现出黑质和非黑质纹状体的病理学改变,以及帕金森病的运动和非运动症状。
Parkinsons Dis. 2011 Feb 21;2011:124165. doi: 10.4061/2011/124165.
2
Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity.在一种单胺储存能力降低的动物模型中揭示的帕金森病非运动症状。
J Neurosci. 2009 Jun 24;29(25):8103-13. doi: 10.1523/JNEUROSCI.1495-09.2009.
3
Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.囊泡中儿茶酚胺储存减少导致蓝斑进行性退变。
Neuropharmacology. 2014 Jan;76 Pt A(0 0):97-105. doi: 10.1016/j.neuropharm.2013.08.033. Epub 2013 Sep 8.
4
Age-related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson's disease.在帕金森病的一种基因小鼠模型中,纹状体多巴胺含量和运动能力的年龄相关性下降在黑质细胞未丢失的情况下出现。
Eur J Neurosci. 2006 Nov;24(9):2622-30. doi: 10.1111/j.1460-9568.2006.05143.x.
5
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration.多巴胺囊泡储存减少会导致进行性黑质纹状体神经变性。
J Neurosci. 2007 Jul 25;27(30):8138-48. doi: 10.1523/JNEUROSCI.0319-07.2007.
6
Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease.多巴胺转运体和囊泡单胺转运体基因敲除小鼠:对帕金森病的影响
Methods Mol Med. 2001;62:179-90. doi: 10.1385/1-59259-142-6:179.
7
Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson's disease motor symptoms without neuronal degeneration in adult mice.在成年小鼠中,遗传消除黑质纹状体通路中的多巴胺囊泡库存会复制帕金森病的运动症状,而不会导致神经元变性。
Sci Rep. 2017 Sep 29;7(1):12432. doi: 10.1038/s41598-017-12810-9.
8
Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson's disease.多巴胺稳态的后天失调重现了帕金森病的特征。
NPJ Parkinsons Dis. 2020 Nov 13;6(1):34. doi: 10.1038/s41531-020-00134-x.
9
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice.NF-κB/c-Rel基因缺陷导致小鼠出现帕金森病样前驱症状和进行性病理变化。
Transl Neurodegener. 2019 May 21;8:16. doi: 10.1186/s40035-019-0154-z. eCollection 2019.
10
Neonatal Reserpine Administration Produces Widespread Neuronal Losses and ⍺-Synuclein Inclusions in a Rat Model.新生大鼠给予利血平会导致广泛的神经元丢失和 ⍺-突触核蛋白包涵体。
Neurotox Res. 2021 Dec;39(6):1762-1770. doi: 10.1007/s12640-021-00434-x. Epub 2021 Nov 2.

引用本文的文献

1
The BE (2)-M17 neuroblastoma cell line: revealing its potential as a cellular model for Parkinson's disease.BE(2)-M17神经母细胞瘤细胞系:揭示其作为帕金森病细胞模型的潜力。
Front Cell Neurosci. 2024 Nov 26;18:1485414. doi: 10.3389/fncel.2024.1485414. eCollection 2024.
2
Effect of altered production and storage of dopamine on development and behavior in .多巴胺生成和储存的改变对……发育及行为的影响
Front Toxicol. 2024 Aug 16;6:1374866. doi: 10.3389/ftox.2024.1374866. eCollection 2024.
3
Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology.

本文引用的文献

1
Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity.在一种单胺储存能力降低的动物模型中揭示的帕金森病非运动症状。
J Neurosci. 2009 Jun 24;29(25):8103-13. doi: 10.1523/JNEUROSCI.1495-09.2009.
2
Olfactory dysfunction in Parkinson's disease.帕金森病中的嗅觉功能障碍。
Neurosignals. 2008;16(1):35-40. doi: 10.1159/000109757. Epub 2007 Dec 5.
3
Inhibition of vesicular monoamine transporter-2 activity in alpha-synuclein stably transfected SH-SY5Y cells.在稳定转染α-突触核蛋白的SH-SY5Y细胞中抑制囊泡单胺转运体2活性。
固有细胞类型特异性神经生物学调节的选择性多巴胺能神经毒性。
Neurotoxicology. 2024 Jul;103:266-287. doi: 10.1016/j.neuro.2024.06.016. Epub 2024 Jul 2.
4
Synaptic vesicle glycoprotein 2C enhances vesicular storage of dopamine and counters dopaminergic toxicity.突触囊泡糖蛋白 2C 增强多巴胺囊泡储存,并对抗多巴胺能毒性。
Eur J Neurosci. 2024 May;59(10):2483-2501. doi: 10.1111/ejn.16311. Epub 2024 Mar 26.
5
Disrupted sleep-wake regulation in the MCI-Park mouse model of Parkinson's disease.帕金森病MCI-Park小鼠模型中睡眠-觉醒调节紊乱。
NPJ Parkinsons Dis. 2024 Mar 11;10(1):54. doi: 10.1038/s41531-024-00670-w.
6
Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions.囊泡单胺转运体(VMAT)的区域表达及其在病理状态中的作用。
Heliyon. 2023 Nov 15;9(11):e22413. doi: 10.1016/j.heliyon.2023.e22413. eCollection 2023 Nov.
7
Developmental exposure to the Parkinson's disease-associated organochlorine pesticide dieldrin alters dopamine neurotransmission in α-synuclein pre-formed fibril (PFF)-injected mice.发育暴露于帕金森病相关的有机氯农药狄氏剂会改变α-突触核蛋白原纤维(PFF)注射小鼠中的多巴胺神经传递。
Toxicol Sci. 2023 Oct 30;196(1):99-111. doi: 10.1093/toxsci/kfad086.
8
Dihydroxyphenylacetaldehyde Lowering Treatment Improves Locomotor and Neurochemical Abnormalities in the Rat Rotenone Model: Relevance to the Catecholaldehyde Hypothesis for the Pathogenesis of Parkinson's Disease.二羟苯乙酮降低治疗可改善鱼藤酮诱导的大鼠运动和神经化学异常:与帕金森病发病机制的儿茶醛假说相关。
Int J Mol Sci. 2023 Aug 7;24(15):12522. doi: 10.3390/ijms241512522.
9
Identification of Hub Genes and Potential Molecular Pathogenesis in Substantia Nigra in Parkinson's Disease via Bioinformatics Analysis.通过生物信息学分析鉴定帕金森病黑质中的枢纽基因及潜在分子发病机制
Parkinsons Dis. 2023 Apr 14;2023:6755569. doi: 10.1155/2023/6755569. eCollection 2023.
10
Upregulated DNA Damage-Linked Biomarkers in Parkinson's Disease Model Mice.帕金森病模型小鼠中上调的与 DNA 损伤相关的生物标志物。
ASN Neuro. 2023 Jan-Dec;15:17590914231152099. doi: 10.1177/17590914231152099.
Cell Mol Neurobiol. 2008 Jan;28(1):35-47. doi: 10.1007/s10571-007-9227-0. Epub 2007 Nov 6.
4
Vmat2 heterozygous mutant mice display a depressive-like phenotype.Vmat2杂合突变小鼠表现出抑郁样表型。
J Neurosci. 2007 Sep 26;27(39):10520-9. doi: 10.1523/JNEUROSCI.4388-06.2007.
5
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration.多巴胺囊泡储存减少会导致进行性黑质纹状体神经变性。
J Neurosci. 2007 Jul 25;27(30):8138-48. doi: 10.1523/JNEUROSCI.0319-07.2007.
6
Differential gene expression in the striatum of mice with very low expression of the vesicular monoamine transporter type 2 gene.囊泡单胺转运体2型基因极低表达小鼠纹状体中的差异基因表达
Brain Res. 2007 Jun 4;1152:10-6. doi: 10.1016/j.brainres.2007.03.032. Epub 2007 Mar 15.
7
Norepinephrine: The redheaded stepchild of Parkinson's disease.去甲肾上腺素:帕金森病中备受冷落的角色。
Biochem Pharmacol. 2007 Jul 15;74(2):177-90. doi: 10.1016/j.bcp.2007.01.036. Epub 2007 Feb 3.
8
Non-motor dysfunction in Parkinson's disease.帕金森病的非运动功能障碍
Parkinsonism Relat Disord. 2007 Aug;13(6):323-32. doi: 10.1016/j.parkreldis.2006.12.014. Epub 2007 Mar 8.
9
Age-related decline in striatal dopamine content and motor performance occurs in the absence of nigral cell loss in a genetic mouse model of Parkinson's disease.在帕金森病的一种基因小鼠模型中,纹状体多巴胺含量和运动能力的年龄相关性下降在黑质细胞未丢失的情况下出现。
Eur J Neurosci. 2006 Nov;24(9):2622-30. doi: 10.1111/j.1460-9568.2006.05143.x.
10
Alpha-synuclein overexpression increases cytosolic catecholamine concentration.α-突触核蛋白过表达会增加胞质儿茶酚胺浓度。
J Neurosci. 2006 Sep 6;26(36):9304-11. doi: 10.1523/JNEUROSCI.0519-06.2006.